FDA-approved as Vyleesi, PT-141 is a peptide derived from melanocortin analogs. It is primarily researched for sexual function, specifically libido and arousal, via CNS mechanisms rather than hormonal pathways.

Science:

• Activates melanocortin receptors in the central nervous system.

• Works independently of testosterone or estrogen levels.

• Studied in animal and early human trials for sexual arousal and related behaviors.

Potential Benefits (Research-Based):

• Enhances sexual desire and arousal in both males and females.

• May support erectile function indirectly via CNS pathways.

• Research shows potential for treating sexual dysfunction without altering hormone levels.